LOC100130587: A Drug Target / Disease Biomarker (G100130587)
LOC100130587: A Drug Target / Disease Biomarker
LOC100130587 is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the superfamily of unprotein-like N-acylhydrazine-containing proteins (SAHPs), which are a type of transmembrane protein that can modulate various cellular processes.
One of the unique features of LOC100130587 is its ability to interact with other proteins that are expressed in the brain, such as the neurotransmitter dopamine. This interaction between the protein and dopamine has been shown to play a role in various neurological disorders, including Parkinson's disease and addiction.
In addition to its interaction with dopamine, LOC100130587 has also been shown to interact with other proteins that are involved in the development and progression of cancer. This suggests that LOC100130587 may be a potential drug target or biomarker for various cancers.
The search for new drug targets and biomarkers is a critical part of modern medicine, and LOC100130587 is an exciting example of a protein that is being studied for its potential to interfere with the development and progression of cancer.
Future studies are needed to fully understand the role of LOC100130587 in disease and to determine its potential as a drug target or biomarker. In the meantime, researchers are actively working to develop new techniques for studying this protein and to identify its potential uses in the clinic.
Protein Name: Uncharacterized LOC100130587
The "LOC100130587 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC100130587 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
LOC100130691 | LOC100130698 | LOC100130744 | LOC100130748 | LOC100130872 | LOC100130899 | LOC100130938 | LOC100130987 | LOC100130992 | LOC100131096 | LOC100131107 | LOC100131257 | LOC100131289 | LOC100131372 | LOC100131496 | LOC100131532 | LOC100131626 | LOC100131635 | LOC100131859 | LOC100131877 | LOC100131943 | LOC100132004 | LOC100132062 | LOC100132077 | LOC100132078 | LOC100132249 | LOC100132287 | LOC100132356 | LOC100132609 | LOC100132626 | LOC100132651 | LOC100132686 | LOC100132741 | LOC100132781 | LOC100132797 | LOC100133077 | LOC100133165 | LOC100133177 | LOC100133284 | LOC100133331 | LOC100133920 | LOC100134317 | LOC100134368 | LOC100134391 | LOC100134868 | LOC100190986 | LOC100233156 | LOC100240728 | LOC100240734 | LOC100240735 | LOC100271840 | LOC100272216 | LOC100272217 | LOC100286922 | LOC100287036 | LOC100287290 | LOC100287329 | LOC100287413 | LOC100287792 | LOC100287834 | LOC100287846 | LOC100287944 | LOC100288069 | LOC100288162 | LOC100288208 | LOC100288637 | LOC100288656 | LOC100289230 | LOC100289283 | LOC100289308 | LOC100289333 | LOC100289361 | LOC100289470 | LOC100289473 | LOC100289495 | LOC100289511 | LOC100289561 | LOC100289580 | LOC100289656 | LOC100293211 | LOC100294145 | LOC100335030 | LOC100419773 | LOC100420587 | LOC100421561 | LOC100505498 | LOC100505502 | LOC100505585 | LOC100505664 | LOC100505715 | LOC100505716 | LOC100505841 | LOC100505912 | LOC100505915 | LOC100505978 | LOC100506023 | LOC100506071 | LOC100506076 | LOC100506124 | LOC100506207
